Home
Conditions
Urinary Bladder, Overactive

Clinical trial condition

Urinary Bladder, Overactive

Explore clinical trials studying Urinary Bladder, Overactive. Study availability and eligibility vary by location and protocol.

89 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Urinary Bladder, Overactive trial results

Completed

UK Study Assessing Flexible Dose Fesoterodine in Adults

NCT00806494

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations: Pfizer Investigational Site Ely, Cambridgeshire, United Kingdom

Pfizer Investigational Site Crewe, Cheshire, United Kingdom

Pfizer Investigational Site Fowey, Cornwall, United Kingdom

Pfizer Investigational Site Penzance, Cornwall, United Kingdom

View all 39 locations

View Trial Details

Completed

Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life

NCT00573508

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations: Montgomery, Alabama, United States

Phoenix, Arizona, United States

Tucson, Arizona, United States

Buena Park, California, United States

View all 59 locations

View Trial Details

Completed

516-BOTOX Urinary Incontinence Detrusor

NCT00850733

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations: Not specified

View Trial Details

Completed

A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031

NCT00814736

Conditions: Erectile Dysfunction, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +16 more
Locations: Pfizer Investigational Site Singapore

View Trial Details

Completed

A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients

NCT00368706

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations: Beijing, China

Chongqing, China

Hangzhou, China

Shanghai, China

View Trial Details

Completed

A Study to Evaluate the Efficacy of Tolterodine Prolonged Release Compared With Propiverine for the Treatment of Korean Patients With Overactive Bladder as Assessed by Ambulatory Urodynamic Monitoring

NCT00646880

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +8 more
Locations: Pfizer Investigational Site Seoul, South Korea

View Trial Details

Active, Not Recruiting

Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study

NCT05715268

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +15 more
Locations: University of California San Francisco, Weill Institute for Neurosciences San Francisco, California, United States

View Trial Details

Active, Not Recruiting

Comparison of Concurrent Endoscopic Prostate Surgery With Botox-A Injection and Postoperative Medical Therapy in BPH Patients With Overactive Bladder Symptoms

NCT07554989

Conditions: Bladder Outlet Obstruction, Botulinium Toxin-A, Female Urogenital Diseases, +18 more
Locations: Taksim Egitim Ve Arastirma Hastanesi Istanbul, Turkey (Türkiye)

View Trial Details

Active, Not Recruiting

INTIBIA Pivotal Study

NCT05250908

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +11 more
Locations: Cedars-Sinai Medical Group Beverly Hills, California, United States

Urology Group of Southern California Los Angeles, California, United States

MedStar Washington Hospital Center Washington D.C., District of Columbia, United States

Advanced Urology Associates Daytona Beach, Florida, United States

View all 22 locations

View Trial Details

Urinary Bladder, Overactive

Urinary Bladder, Overactive trial results

Related conditions